首页>美国卫生研究院文献>American Health Drug Benefits

American Health Drug Benefits

【机译】：美国健康药品福利

ISSN：-
出版周期：Nine times a year, 2013-
语言：English

起始发布年份：2008
出版者：Long Valley, NJ : Engage Healthcare Communications, LLC
出版地：United States

数据库引入：PubMed: v5, 2012-, PMC

MeSH词表主题词：Insurance, Pharmaceutical Services*; United States

备注："For payers, purchasers, policymakers, and other healthcare stakeholders". "The展开▼

期刊论文

热门论文

年度选择

更多>>

全选（0）

1.Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service

机译：按肿瘤阶段和服务类型比较乳腺癌的治疗费用
- 作者：Helen Blumen;Kathryn Fitch;Vincent Polkus;Michael Kleinrock;*
- 期刊名称：《American Health Drug Benefits》 | 2011年第1期
- breast cancer, cost, cancer stage, diagnosis;
2.Payer Perspectives on PCSK9 Inhibitors: A Conversation with Stephen Gorshow, MD, and James T. Kenney, RPh, MBA

机译：付款人对PCSK9抑制剂的看法：与医学博士Stephen Gorshow和MBA博士James T. Kenney的对话
- 作者：Stanton R. Mehr;*
- 期刊名称：《American Health Drug Benefits》 | 2011年第1期
3.Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method

机译：学术详图的主要特征：使用Delphi方法开发专家共识
- 作者：James S. Yeh;Thomas J. Van Hoof;Michael A. Fischer;Jack E. Fincham;*
- 期刊名称：《American Health Drug Benefits》 | 2011年第1期
- academic detailing, clinician behavior, Delphi method, educational outreach, expert consensus, health professions education;
4.Alexa Refill My Omeprazole

机译：Alexa补充我的奥美拉唑
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第9期
5.Prospective Bundled Payments in a Changing Environment: The Experience of a Self-Funded State-Sponsored Plan

机译：不断变化的环境中可能发生的捆绑式付款：国家出资的自费计划的经验
- 作者：Frank H. Lawler;Frank R. Wilson;G. Keith Smith;Lynn V. Mitchell;James T. Kenney
- 期刊名称：《American Health Drug Benefits》 | 2017年第9期
- bundled payments healthcare reimbursement reimbursement Select program value-based payments;
6.The Effects of a Sitagliptin Formulary Restriction Program on Diabetes Medication Use

机译：西他列汀处方限制计划对糖尿病药物使用的影响
- 作者：Yuexin Tang;Xingyue Huang;Jinan Liu;R. Ravi Shankar;Michael L. Ganz;Swapnil Rajpathak;Quang T. Nguyen
- 期刊名称：《American Health Drug Benefits》 | 2017年第9期
- diabetes mellitus dipeptidyl peptidase-4 inhibitors drug utilization formulary restriction program managed care programs multitier formulary sitagliptin step therapy;
7.AMCP Nexus 2017 Highlights

机译：AMCP Nexus 2017亮点
- 期刊名称：《American Health Drug Benefits》 | 2017年第9期
8.Comparing the Medicaid Retrospective Drug Utilization Review Program Cost-Savings Methods Used by State Agencies

机译：比较国家机构使用的医疗补助回顾性药物使用审查计划节省成本的方法
- 作者：Sergio I. Prada;Michael Kleinrock;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第9期
- cost-avoidance cost-savings Medicaid Drug Utilization Review program methodology transparency postintervention preintervention retrospective DUR;
9.Opioids Equal Heroin

机译：阿片类药物等于海洛因
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第8期
10.Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor

机译：引发黄嘌呤氧化酶抑制剂的痛风和心血管疾病或心力衰竭和慢性肾脏病患者的主要心血管事件
- 作者：JoAnne Foody;Robin S. Turpin;Beni A. Tidwell;Debra Lawrence;Kathy L. Schulman;Gary M Owens;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第8期
- allopurinol cardiovascular disease chronic kidney disease febuxostat gout hyperuricemia major CV events urate-lowering therapies xanthine oxidase inhibitors;
11.Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

机译：比较奥曲肽长效释放与兰瑞肽治疗转移性胃肠道神经内分泌肿瘤的费用
- 作者：Rajeev Ayyagari;Maureen Neary;Shang Li;Ariel Rokito;Hongbo Yang;Jipan Xie;Al B. Benson III
- 期刊名称：《American Health Drug Benefits》 | 2017年第8期
- adverse events Average Sales Price CLARINET GI-NETs lanreotide octreotide LAR PROMID sensitivity analyses treatment cost Wholesale Acquisition Cost;
12.The Value of Pre–FDA Approval Healthcare Economic Information Exchange Between Payers and Drug Manufacturers

机译：付款人与药品制造商之间进行FDA批准前的医疗保健经济信息交换的价值
- 作者：Peter R. Fendt;Brian Ung;F. Randy Vogenberg
- 期刊名称：《American Health Drug Benefits》 | 2017年第8期
13.Health Inequities in America

机译：美国的健康不平等
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第6期
14.Costs and Effectiveness of Mindfulness-Based Art Therapy versus Standard Breast Cancer Support Group for Women with Cancer

机译：基于正念的艺术疗法与标准乳腺癌女性支持小组的费用和有效性
- 作者：Katherine M. Prioli;Laura T. Pizzi;Kathryn M. Kash;Andrew B. Newberg;Anna Marie Morlino;Michael J. Matthews;Daniel A. Monti;Linda Bily;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第6期
- art therapy behavioral medicine breast cancer support group integrative medicine mindfulness-based stress reduction nontraditional supportive interventions;
15.Medication Adherence Treatment Patterns and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide

机译：接受醋酸阿比特龙酯或恩扎鲁胺治疗的转移性去势抵抗性前列腺癌患者的药物依从性治疗方式和剂量减少
- 作者：Ajay S. Behl;Lorie A. Ellis;Dominic Pilon;Yongling Xiao;Patrick Lefebvre;Gary M. Owens;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第6期
- abiraterone acetate therapy dose reduction enzalutamide therapy medication adherence medication possession ratio metastatic castration-resistant prostate cancer proportional hazards survival treatment patterns;
16.The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data

机译：绝经和绝经后症状与其他主要疾病的相对负担：医疗支出小组调查数据的回顾性分析
- 作者：Annlouise R. Assaf;Andrew G. Bushmakin;Nina Joyce;Michael J. Louie;Michael Flores;Margaret Moffatt;JoAnn V. Pinkerton;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第6期
- direct cost of care healthcare costs hysterectomy Medical Expenditure Panel Survey data menopause;
17.Trending BIO

机译：热门生物
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第7期
18.Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers

机译：运用更多的多元检测方法指导卵巢癌治疗的经济影响：对付款人的影响
- 作者：Burton S. Brodsky;Gary M. Owens;Dennis J. Scotti;Keith A. Needham;Christina L. Cool;F. Randy Vogenberg;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第7期
- budget impact analysis CA125 gynecologic oncologist Medicare multivariate assay OVA1 ovarian cancer pelvic mass postmenopausal women premenopausal women;
19.The Cost of Hematopoietic Stem-Cell Transplantation in the United States

机译：美国造血干细胞移植的成本
- 作者：Michael S. Broder;Tiffany P. Quock;Eunice Chang;Sheila R. Reddy;Rajni Agarwal-Hashmi;Sally Arai;Kathleen F. Villa;James T. Kenney;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第7期
- allogeneic HSCT autologous HSCT healthcare costs hospitalization inpatient myeloablative conditioning regimen nonmyeloablative/reduced-intensity conditioning regimen;
20.Commencement 2017

机译：2017年开学
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第5期
21.The Medical and Economic Burden of Narcolepsy: Implications for Managed Care

机译：发作性睡病的医疗和经济负担：对管理照护的影响
- 作者：Michael J. Thorpy;George Hiller;James T. Kenney;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第5期
- cataplexy chronic sleepiness cost containment daytime sleepiness managed care narcolepsy prevalence rapid eye movement sleep;
22.Emphasize Shared Decision-Making Between Physicians and Patients to Improve Diabetes Outcomes

机译：强调医师和患者之间的共同决策以改善糖尿病的结果
- 作者：Gary Branning;*;Stacey L. Worthy;Martha Vater
- 期刊名称：《American Health Drug Benefits》 | 2017年第5期
23.Value Frameworks in Oncology: Comparative Analysis and Implications to the Pharmaceutical Industry

机译：肿瘤学的价值框架：比较分析及其对制药行业的启示
- 作者：Mark Slomiany;Priya Madhavan;Michael Kuehn;Sasha Richardson;Matthew Mitchell;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第5期
- aggregate analysis clinical trials healthcare stakeholder oncology drug costs value framework;
24.Budget Impact of a Comprehensive Nutrition-Focused Quality Improvement Program for Malnourished Hospitalized Patients

机译：营养不良住院患者以营养为中心的全面质量改进计划的预算影响
- 作者：Suela Sulo;Josh Feldstein;Jamie Partridge;Bjoern Schwander;Krishnan Sriram;Wm. Thomas Summerfelt;Jack E. Fincham;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第5期
- budget impact model cost-savings hospital length of stay hospital readmissions hospital setting malnourished inpatients nutrition-focused interventions quality improvement program value-based medicine;
25.Sunshine Is the Best Disinfectant

机译：阳光是最好的消毒剂
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第4期
26.Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas

机译：使用钠-葡萄糖共转运蛋白2抑制剂或磺脲类药物比较2型糖尿病患者的药物依从性和持久性
- 作者：Kelly F. Bell;Katherine Cappell;Michael Liang;Amanda M. Kong;Brian Caveney;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第4期
- adherence antidiabetes medication glycemic control persistence SGLT-2 inhibitor sulfonylureas type 2 diabetes;
27.Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes

机译：胰高血糖素样肽1受体激动剂概述2型糖尿病患者的治疗
- 作者：Kelvin Lingjet Tran;Young In Park;Shalin Pandya;Navin John Muliyil;Brandon David Jensen;Kovin Huynh;Quang T. Nguyen;Raymond Plodkowski;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第4期
- albiglutide diabetes DPP-4 inhibitors dulaglutide exenatide GLP-1 receptor agonists incretin-based therapy insulin liraglutide lixisenatide metformin semaglutide sulfonylureas type 2 diabetes;
28.Challenges and Opportunities in Managing Type 2 Diabetes

机译：管理2型糖尿病的挑战与机遇
- 作者：Laura Morgan
- 期刊名称：《American Health Drug Benefits》 | 2017年第4期
29.The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers

机译：高钾血症对医疗保险和商业付款人的临床和经济负担
- 作者：Kathryn Fitch;J. Michael Woolley;Tyler Engel;Helen Blumen;Quang T. Nguyen;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第4期
- chronic kidney disease commercially insured comorbidities cost fee for service hyperkalemia Medicare mortality prevalence utilization;
30.Guru Insights

机译：大师见解
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第3期
31.Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea

机译：与酒渣鼻局部治疗相关的不良事件发生率和医疗保健费用
- 作者：Todd Williamson;Rajesh Kamalakar;Augustina Ogbonnaya;Erin A. Zagadailov;Michael Eaddy;Charlie Kreilick;Atheer A. Kaddis;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第3期
- adherence adverse event azelaic acid benzoyl peroxide metronidazole rosacea sodium sulfacetamide/sulfur topical treatment treatment cost treatment discontinuation treatment switch;
32.Academic Detailing Has a Positive Effect on Prescribing and Decreasing Prescription Drug Costs: A Health Plans Perspective

机译：学术细节对处方药成本的降低和处方产生积极影响：卫生计划的观点
- 作者：Uche Anadu Ndefo;Rolicia Norman;Andrea Henry;Jack E. Fincham;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第3期
- academic detailing antibiotics cefixime prescribing prescription drug costs;
33.Multispecialty Rating of Evidence-Based Conditions for Intravenous Immunoglobulin Therapy Using a 3-Axis Prioritization Algorithm

机译：使用三轴优先算法对静脉免疫球蛋白治疗的循证条件进行多专业评分
- 作者：Jordan S. Orange;Matt Johnson;Barb Lennert;Katarzyna Shields;Michael Eaddy;Gary Branning;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第3期
- AAAAI consensus building disease severity disease state efficacy evidence-based medicine intravenous immunoglobulin prioritization algorithm;
34.Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate Bicalutamide Enzalutamide or Chemotherapy

机译：使用醋酸阿比特龙比卡鲁胺恩杂鲁胺或化学疗法评估晚期前列腺癌患者真实世界的中枢神经系统事件
- 作者：Dominic Pilon;Ajay S. Behl;Lorie A. Ellis;Marie-Noëlle Robitaille;Patrick Lefebvre;Nancy A. Dawson;Brian Caveney;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第3期
- abiraterone acetate advanced prostate cancer bicalutamide central nervous system events chemotherapy enzalutamide;
35.Reflections Predictions and Admonitions

机译：反思预测和告诫
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第2期
36.Does a Free Office Visit Affect Primary Care–Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi

机译：免费上门拜访会影响基层医疗寻求行为吗？密西西比州的新交流健康计划参与者研究
- 作者：Bettina M. Beech;Tristan Cordier;Laura E. Happe;Laura Trunk;Gilbert S. Haugh;Richard Kwong;Vipin Gopal;Roy A. Beveridge;James T. Kenney Jr;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第2期
- barrier to care copay cost of care exchange health plans nonpreventive visit office visit preventive care primary care provider primary care–seeking behavior;
37.Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis

机译：比较在有和没有阿片类药物引起的便秘的慢性非癌痛医疗补助患者中的医疗利用和费用：一项回顾性分析
- 作者：Tope Olufade;Amanda M. Kong;Nicole Princic;Paul Juneau;Rucha Kulkarni;Kui Zhang;Catherine Datto;Jack E. Fincham;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第2期
- chronic pain constipation costs healthcare utilization Medicaid noncancer pain opioid-induced constipation opioids propensity score matching side effects;
38.Payers Perspective: Incorporating Real-World Evidence in Patient Care

机译：付款人的观点：将现实世界的证据纳入患者护理
- 作者：Lilly Ostrovsky
- 期刊名称：《American Health Drug Benefits》 | 2017年第2期
39.Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population

机译：不坚持吸入皮质类固醇/ LABA治疗对美国商业保险人群中COPD恶化率和医疗保健费用的影响
- 作者：Jill R. Davis;Bingcao Wu;David M. Kern;Ozgur Tunceli;Kathleen M. Fox;John Horton;Randall F. Legg;Frank Trudo;Michael F. Murphy;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第2期
- adherence COPD cost disease exacerbation economic burden inhaled corticosteroid/LABA nonadherence propensity score matching proportion of days covered;
40.The Dream of Value-Based Care

机译：基于价值的护理梦想
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第1期
41.Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis

机译：使用类风湿关节炎处方药的患者的自付费用的社会人口统计学决定因素
- 作者：Kumar Mukherjee;Khalid M. Kamal;F. Randy Vogenberg;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第1期
- analgesics biologics comorbidities corticosteroids disease-modifying antirheumatic drugs generalized linear model income level insurance status Medical Expenditure Panel Survey nonsteroidal anti-inflammatory drugs out-of-pocket expenditures prescription drugs rheumatoid arthritis sociodemographics uninsured patients;
42.Pharmaceutical Patent Litigation and the Emerging Biosimilars: A Conversation with Kevin M. Nelson JD

机译：药品专利诉讼和新兴生物仿制药：与JD Kevin M. Nelson的对话
- 作者：Stanton R. Mehr
- 期刊名称：《American Health Drug Benefits》 | 2017年第1期
43.Biologic Disease-Modifying Antirheumatic Drugs in a National Privately Insured Population: Utilization Expenditures and Price Trends

机译：全国有个人保险的人群中的抗生物风湿病药物：利用支出和价格趋势
- 作者：Christopher B. Atzinger;Jeff J. Guo;Byron C. Scott;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第1期
- biologic disease-modifying antirheumatic drugs drug utilization expenditures out-of-pocket cost price trends rheumatoid arthritis;
44.Top 10 Healthcare Market Trends in 2017

机译：2017年十大医疗保健市场趋势
- 作者：John Santilli;*;F. Randy Vogenberg;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第1期
45.Comparing Healthcare Costs Associated with Oral and Subcutaneous Methotrexate or Biologic Therapy for Rheumatoid Arthritis in the United States

机译：在美国比较与口服和皮下甲氨蝶呤或生物疗法治疗类风湿性关节炎相关的医疗保健费用
- 作者：Joseph Lee;Ryan Pelkey;Julieanna Gubitosa;Michael F. Henrick;Michael L. Ganz;Gary Branning;*
- 期刊名称：《American Health Drug Benefits》 | 2017年第1期
- biologic therapy healthcare cost MTX oral methotrexate rheumatoid arthritis subcutaneous methotrexate treatment pathways;
46.Shut Off the Faucet and Stop Mopping the Floor

机译：关闭水龙头然后停止擦地板
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第9期
47.Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

机译：每天一次的急性细菌性皮肤和皮肤结构感染患者使用氨甲基环素抗生素与万古霉素的潜在成本节约
- 作者：Ken LaPensee;Thomas Lodise;Michael F. Murphy;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第9期
- acute bacterial skin and skin structure aminomethylcycline antibiotics cost-savings economic modeling hospitalized patients hospital stay infections inpatient cost intravenous omadacycline outpatient cost skin infections vancomycin;
48.Pharmacist-Led Drug Therapy Problem Management in an Interprofessional Geriatric Care Continuum: A Subset of the PIVOTS Group

机译：专业间老年医学连续体中以药剂师为主导的药物治疗问题管理：PIVOTS组的子集
- 作者：Ashley M. Campbell;Kim C. Coley;Jason M. Corbo;Teresa M. DeLellis;Matthew Joseph;Carolyn T. Thorpe;Melissa S. McGivney;Patricia Klatt;Lora Cox-Vance;Vincent Balestrino;Heather Sakely;Jack E. Fincham;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第9期
- assisted-living facilities drug therapy problems geriatric patients geriatric pharmacists interprofessional medication dosing skilled-nursing facility transitions of care;
49.A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation in a Tertiary Eye Care Center

机译：拟采取的干预措施以减少三级眼保健中心住院医师进行的白内障手术取消
- 作者：Eileen L. Mayro;Laura T. Pizzi;Lisa A. Hark;Ann P. Murchison;Douglas Wisner;Anish Koka;Benjamin E. Leiby;Nooreen Dabbish;Adedoyin Okulate;Alexa Dessy;Caitlin Green;Robert Bailey
- 期刊名称：《American Health Drug Benefits》 | 2018年第9期
- blindness cataract cataract surgery ophthalmology residency training preadmission testing resident-performed surgery surgery cancellation usual care;
50.Unscaling Population Health

机译：不断扩大的人口健康
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第8期
51.Healthcare Costs and Absenteeism Among Caregivers of Adults with Partial-Onset Seizures: Analysis of Claims from an Employer Database

机译：成年人部分发作的看护者的医疗费用和缺勤：雇主数据库中索赔的分析
- 作者：Richard A. Brook;Krithika Rajagopalan;James E. Smeeding;Michael Kleinrock;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第8期
- absenteeism adjunctive therapy antiepileptic drugs caregiver burden caregivers direct healthcare cost epilepsy indirect healthcare cost monotherapy partial-onset seizures treatment decision-making;
52.Patient Preferences Associated with Therapies for Psoriatic Arthritis: A Conjoint Analysis

机译：银屑病关节炎的治疗相关的患者偏爱：联合分析。
- 作者：Yihua Xu;Lavanya Sudharshan;Ming-Ann Hsu;Andrew S. Koenig;Joseph C. Cappelleri;Wen F. Liu;Timothy W. Smith;Margaret K. Pasquale;F. Randy Vogenberg;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第8期
- conjoint analysis medication attributes patient preferences psoriatic arthritis route of administration treatment decisions;
53.FDA Commissioner Outlines New Plan to Increase Biosimilars by Balancing Innovation and Competition

机译：FDA专员概述了通过平衡创新和竞争来增加生物仿制药的新计划
- 作者：Eileen Koutnik-Fotopoulos
- 期刊名称：《American Health Drug Benefits》 | 2018年第8期
54.Treatment Tolerability in Patients with Immunoglobulin Light-Chain Amyloidosis

机译：免疫球蛋白轻链淀粉样变性病患者的治疗耐受性
- 作者：Avery A. Rizio;Michelle K. White;Kristen L. McCausland;Tiffany P. Quock;Spencer D. Guthrie;Miyo Yokota;Martha S. Bayliss
- 期刊名称：《American Health Drug Benefits》 | 2018年第8期
- adverse events health-related quality of life immunoglobulin light-chain amyloidosis treatment discontinuation treatment tolerability;
55.Hoodoo You Think Will Change?

机译：您认为 Hoodoo会改变吗？
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第7期
56.Economic Burden of Adverse Events Associated with Immunotherapy and Targeted Therapy for Metastatic Melanoma in the Elderly

机译：老年人转移性黑色素瘤免疫治疗和靶向治疗相关不良事件的经济负担
- 作者：Sameer R. Ghate;Zhiyi Li;Jackson Tang;Antonio Reis Nakasato;Gary M. Owens;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第7期
- adverse events economic burden elderly patients immunotherapy metastatic melanoma targeted therapy treatment-related costs;
57.Computed Tomography Colonography Less Costly Than Colonoscopy for Colorectal Cancer Screening of Commercially Insured Patients

机译：计算机断层扫描结肠镜检查比结肠镜检查更便宜可用于商业保险患者的大肠癌筛查
- 作者：Tia Goss Sawhney;Bruce S. Pyenson;David Rotter;Michele Berrios;Judy Yee
- 期刊名称：《American Health Drug Benefits》 | 2018年第7期
- colonoscopy colorectal cancer cost-effectiveness CRC screening CT colonography optical colonoscopy;
58.Alternative Payment Models in Medical Oncology: Assessing Quality-of-Care Outcomes Under Partial Capitation

机译：医学肿瘤学中的替代支付模型：部分人为情况下评估护理质量结果
- 作者：Derek Ems;Sharanya Murty;Bryan Loy;Judith Gallagher;Laura E. Happe;Teresa L. Rogstad;Debra Finnel;Jimmy D. Fernandez
- 期刊名称：《American Health Drug Benefits》 | 2018年第7期
- alternative payment models ambulance transport bundled payments capitated payment chemotherapy-related complications Medicare Advantage plans oncology service partial-capitated payment primary care quality of care;
59.Budget Impact Analysis of Using Daunorubicin-Cytarabine Liposome in Patients with Newly Diagnosed Therapy-Related AML or AML and Myelodysplasia-Related Changes

机译：新诊断与治疗有关的AML或AML与骨髓增生异常有关的患者使用柔红霉素-阿糖胞苷脂质体的预算影响分析
- 作者：Ivar S. Jensen;Elizabeth Wu;Naomi C. Sacks;Philip L. Cyr;Karen C. Chung
- 期刊名称：《American Health Drug Benefits》 | 2018年第7期
- acute myelogenous leukemia AML with myelodysplasia-related changes budget impact daunorubicin-cytarabine liposome incremental cost 7+3 regimen tAML therapy-related AML;
60.The Dirty Dozen

机译：肮脏的一打
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第6期
61.Trends in Utilization Spending and Prices of Smoking-Cessation Medications in Medicaid Programs: 25 Years Empirical Data Analysis 1991–2015

机译：医疗补助计划中戒烟药物的利用消费和价格的趋势：1991年至2015年的25年经验数据分析
- 作者：Xiaomeng Yue;Jeff Jianfei Guo;Patricia R. Wigle;Jack E. Fincham;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第6期
- drug utilization Medicaid nicotine replacement therapy nonnicotine prescription reimbursement smoking smoking-cessation medication;
62.Analysis of Real-World Dosing Patterns for the 3 FDA-Approved Medications in the Treatment of Fibromyalgia

机译：FDA批准的3种药物治疗纤维肌痛的实际给药方式分析
- 作者：Craig White;Winghan Jacqueline Kwong;Hilary Armstrong;Michael Behling;Jeffrey Niemira;Kathy Lang;F. Randy Vogenberg;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第6期
- dosing patterns duloxetine fibromyalgia milnacipran pregabalin recommended dose treatment duration;
63.Estimating the Real-World Cost of Diabetes Mellitus in the United States During an 8-Year Period Using 2 Cost Methodologies

机译：使用2种成本方法估算美国在8年内的现实世界糖尿病成本
- 作者：Vincent J. Willey;Sheldon Kong;Bingcao Wu;Amit Raval;Todd Hobbs;Andrea Windsheimer;Gaurav Deshpande;Ozgur Tunceli;Brian Sakurada;Jonathan R. Bouchard
- 期刊名称：《American Health Drug Benefits》 | 2018年第6期
- cost-estimation method cost projection diabetes disease prevalence healthcare utilization prevalence type 1 diabetes type 2 diabetes;
64.Namaste

机译：你好
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第5期
65.Assessing the Level of Patient-Specific Treatment Recommendations in Clinical Practice Guidelines for Hemodialysis Vascular Access in the United States

机译：在美国血液透析血管通路临床实践指南中评估患者特定治疗建议的水平
- 作者：Gilbert L. Queeley;Ellen S. Campbell;Askal A. Ali;Raymond L. Singer;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第5期
- clinical practice guidelines dialysis end-stage renal disease hemodialysis patient-specific treatment recommendations vascular access;
66.The Prevalence and Payer Costs of Potentially Avoidable Emergent Care Visits for Suspected Amniotic Membrane Rupture in Pregnant Women

机译：孕妇疑似羊膜破裂可能避免的紧急护理就诊的发生率和支付者费用
- 作者：Christine Ferro;Bruce S. Pyenson;Jocelyn Lau;Mona Kelkar;Nancy Phillips;Chi-Wei Lu;Percy Yeung;Gloria Bachmann;Eliza Ng;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第5期
- amniotic fluid leakage avoidable costs emergent care visits labor and delivery payer costs prelabor rupture of amniotic membranes self-monitoring suspected PROM;
67.Budget Impact of Adding Vedolizumab to a Health Plan Formulary as Another First-Line Biologic Option for Ulcerative Colitis and Crohns Disease

机译：将维多珠单抗作为溃疡性结肠炎和克罗恩氏病的另一种第一线生物选择加入健康计划的预算影响
- 作者：Michele Wilson;Aaron Lucas;Ann Cameron;Michelle Luo
- 期刊名称：《American Health Drug Benefits》 | 2018年第5期
- adalimumab anti-TNF biologic drug budget impact model certolizumab Crohns disease golimumab health plan formulary infliximab ulcerative colitis vedolizumab;
68.Can We Make Medicines Affordable?

机译：我们可以负担得起药品吗？
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第4期
69.Prior Authorization for Elective Diagnostic Catheterization: The Value of Reviewers in Cases with Clinical Ambiguity

机译：选择性诊断导管插入术的事先授权：审阅者在临床歧义病例中的价值
- 作者：Adam C. Powell;Stephen E. Price;Khoa Nguyen;Gary L. Smith;James W. Long;Uday U. Deshmukh;Raymond L. Singer;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第4期
- cardiac catheterization decision support systems prior authorization rule systems specialty benefit management;
70.Long-Term Outcomes of a Cardiovascular and Diabetes Risk-Reduction Program Initiated by a Self-Insured Employer

机译：由自保雇主发起的心血管和糖尿病风险降低计划的长期结果
- 作者：Nicole D. White;Thomas L. Lenz;Maryann Z. Skrabal;Jessica J. Skradski;Louis Lipari;Jack E. Fincham;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第4期
- cardiovascular disease cardiovascular risk diabetes disease management employer-sponsored program healthcare cost lifestyle behavior quality of life risk reduction work productivity;
71.Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy

机译：目标疗法改变后类风湿关节炎患者的治疗持续性和医疗费用
- 作者：Machaon M. K. Bonafede;Donna McMorrow;Clare Proudfoot;Shraddha Shinde;Andreas Kuznik;Chieh-I Chen
- 期刊名称：《American Health Drug Benefits》 | 2018年第4期
- alternative mechanisms of action cost persistence rheumatoid arthritis switching treatment synthetic DMARD treatment cycling treatment persistence tumor necrosis factor inhibitors;
72.Can Technologic Innovations and Formulary Considerations Improve Healthcare Outcomes?

机译：技术创新和配方考虑因素能否改善医疗保健成果？
- 作者：Charles Bankhead
- 期刊名称：《American Health Drug Benefits》 | 2018年第4期
73.Oncology Drugs Approved by the FDA in Early 2018

机译：FDA在2018年初批准的肿瘤药物
- 期刊名称：《American Health Drug Benefits》 | 2018年第4期
74.Is Adequate Nutrition Cost-Effective?

机译：营养充足是否合算？
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第3期
75.Comparing Treatment Modalities for End-Stage Renal Disease: A Meta-Analysis

机译：比较终末期肾脏疾病的治疗方式：一项荟萃分析
- 作者：Gilbert L. Queeley;Ellen S. Campbell;Michael F. Murphy;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第3期
- end-stage renal disease health-related quality of life hemodialysis peritoneal dialysis random-effects model subgroup analysis;
76.Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States

机译：美国发作性睡病诊断后医疗服务和药物利用的变化以及相关费用
- 作者：Kathleen F. Villa;Nancy L. Reaven;Susan E. Funk;Karen McGaughey;Jed Black;James T. Kenney;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第3期
- healthcare costs healthcare utilization medical service utilization multiple sleep latency testing narcolepsy;
77.Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry

机译：对最初的肿瘤坏死因子抑制剂反应不足的类风湿关节炎患者的延迟治疗加速：Corrona Registry的数据
- 作者：Dimitrios A. Pappas;Robert A. Gerber;Heather J. Litman;David Gruben;Jamie Geier;Winnie D. Hua;Connie Chen;Youfu Li;Joel M. Kremer;John S. Andrews;Jeffrey A. Bourret;Gary Branning;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第3期
- arthritis Corrona registry registries response to therapy rheumatoid arthritis tumor necrosis factor inhibitor;
78.20% by 2020

机译：到2020年达到20％
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 1995年第2期
79.Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System

机译：高成本药物使用的标准化审查和批准过程可促进大型学术医疗系统中基于价值的护理
- 作者：Raghu Durvasula;Janet Kelly;Anneliese Schleyer;Bradley D. Anawalt;Shabir Somani;Timothy H. Dellit;Byron C. Scott;*
- 期刊名称：《American Health Drug Benefits》 | 1995年第2期
- cost-containment, medication utilization, pharmacy costs, practice transformation, process improvement, specialty medications, standardized review process, stewardship, value-based care;
80.New Rivals: Integrating Health Benefits to Provide Comprehensive Patient Care

机译：新对手：整合健康益处以提供全面的患者护理
- 作者：Gary Branning;*;Martha Vater
- 期刊名称：《American Health Drug Benefits》 | 1995年第2期
81.Effects of Educational Messaging on Urgent and Emergent Care–Seeking Behaviors Among Publicly Insured Populations

机译：教育信息对公共保险人群中紧急求助行为的影响
- 作者：Jesse Cambon;Tristan Cordier;Elizabeth L. Munnich;Andrew Renda;Bobby Kapur;Shkelzen Hoxhaj;Meredith Williams;Cody Olsen;*
- 期刊名称：《American Health Drug Benefits》 | 1995年第2期
- care-seeking behavior, emergency department, emergent care, in-network providers, messaging strategies, out-of-network providers, urgent care;
82.Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study

机译：酒渣鼻的患者偏爱和局部用药的治疗满意度：一项基于调查的研究
- 作者：Todd Williamson;Wendy Y. Cheng;Nora McCormick;Francis Vekeman;Gary M. Owens;*
- 期刊名称：《American Health Drug Benefits》 | 1995年第2期
- patient preferences, quality of life, rosacea, side effects, topical treatments, treatment satisfaction;
83.Still at It

机译：仍在
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第1期
84.Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States

机译：美国工作年龄成年人向事件性慢性阿片类药物治疗过渡的预测因素
- 作者：J. Douglas Thornton;Nilanjana Dwibedi;Virginia Scott;Charles D. Ponte;Douglas Ziedonis;Nethra Sambamoorthi;Usha Sambamoorthi;Albert Tzeel
- 期刊名称：《American Health Drug Benefits》 | 2018年第1期
- chronic opioid use chronic pain databases decision tree noncancer pain opioid regimen pharmacoepidemiology predictive modeling;
85.Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines

机译：2012年实施扩大筛查指南前后在美国商业保险人群中新诊断的丙型肝炎
- 作者：Bruce S. Pyenson;Gabriela Dieguez;Christine Ferro;Maushumi Mavinkurve;Yuri Sanchez Gonzalez;Jack E. Fincham
- 期刊名称：《American Health Drug Benefits》 | 2018年第1期
- administrative claims analysis hepatitis C infection newly diagnosed hepatitis screening guidelines undiagnosed hepatitis;
86.Temporal Trends in Survival and Healthcare Costs in Patients with Multiple Myeloma in the United States

机译：美国多发性骨髓瘤患者生存和医疗费用的时间趋势
- 作者：Eric M. Maiese;Kristin A. Evans;Bong-Chul Chu;Debra E. Irwin;Matthew Mitchell
- 期刊名称：《American Health Drug Benefits》 | 2018年第1期
- healthcare costs mortality multiple myeloma survival;
87.Healthcare Trends for 2018

机译：2018年医疗保健趋势
- 作者：F. Randy Vogenberg;John Santilli;*
- 期刊名称：《American Health Drug Benefits》 | 2018年第1期
88.Final Commencement Address

机译：最终开学地址
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2019年第4期
89.Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models

机译：社区获得性细菌性肺炎住院患者口服和静脉用药一次每天一次的氨基甲基环素抗生素的节省成本的机会：决策分析模型的发现。
- 作者：Thomas Lodise;Kenneth LaPensee
- 期刊名称：《American Health Drug Benefits》 | 2019年第4期
- antibiotics azithromycin ceftriaxone community-acquired bacterial pneumonia cost-savings healthcare decision models hospital stay intravenous antibiotics macrolide omadacycline oral antibiotics;
90.Will We Ever Bend the Cost Curve in Healthcare?

机译：我们会弯曲医疗保健的成本曲线吗？
- 作者：Ehsan U. Syed
- 期刊名称：《American Health Drug Benefits》 | 2019年第4期
91.Charlson Comorbidity Index: ICD-9 Update and ICD-10 Translation

机译：查尔森合并症指数：ICD-9更新和ICD-10翻译
- 作者：William P. Glasheen;Tristan Cordier;Rajiv Gumpina;Gil Haugh;Jared Davis;Andrew Renda
- 期刊名称：《American Health Drug Benefits》 | 2019年第4期
- CCI coding instrument CDMF scheme Charlson Comorbidity Index diabetes HIV/AIDS ICD-9 ICD-10 morbidity risk morbidity score mortality risk renal disease risk assessment;
92.FDA Oncology Update

机译：FDA肿瘤学更新
- 期刊名称：《American Health Drug Benefits》 | 2019年第4期
93.Group-Based Trajectory Models to Identify Sociodemographic and Clinical Predictors of Adherence Patterns to Statin Therapy Among Older Adults

机译：基于组的轨迹模型来识别老年人的他汀类药物治疗依从性的社会人口统计学和临床预测指标
- 作者：Aisha Vadhariya;Marc L. Fleming;Michael L. Johnson;E. James Essien;Omar Serna;Tara Esse;Jeannie Choi;Susan H. Boklage;Susan M. Abughosh
- 期刊名称：《American Health Drug Benefits》 | 2019年第4期
- adherence cardiovascular disease elderly patients nonadherence predictors of statin adherence statin therapy trajectory modeling;
94.Lexicon Limbo: From Healthspan to New Normal and Discharge

机译：词典Limbo：从 Healthspan到 New Normal和 Discharge
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2019年第3期
95.Treatment Patterns and Costs of Chronic Inflammatory Demyelinating Polyneuropathy: A Claims Database Analysis

机译：慢性炎性脱髓鞘性多发性神经病的治疗方式和费用：索赔数据库分析
- 作者：Jeffrey T. Guptill;M. Chris Runken;Michael Eaddy;Orsolya Lunacsek;Rupali M. Fuldeore;James T. Kenney;*
- 期刊名称：《American Health Drug Benefits》 | 2019年第3期
- chronic inflammatory demyelinating polyneuropathy CIDP economic burden healthcare costs intravenous immunoglobulin IVIG plasma exchanges steroids treatment patterns;
96.Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone Metastases

机译：去势抵抗性前列腺癌和骨转移患者的真实治疗模式
- 作者：Lonnie Wen;Adriana Valderrama;Mary E. Costantino;Stacey Simmons
- 期刊名称：《American Health Drug Benefits》 | 2019年第3期
- abiraterone acetate androgen-deprivation therapy bone metastases cabazitaxel docetaxel enzalutamide hormone therapy metastatic castrate-resistant prostate cancer prostate cancer radium-223 dichloride real-world treatment sipuleucel-T;
97.Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population

机译：制度化医疗保险收费服务人群中癫痫的患病率和经济负担
- 作者：Kathryn Fitch;Xiaoyun Pan;Jocelyn Lau;Tyler Engel;Krithika Rajagopalan
- 期刊名称：《American Health Drug Benefits》 | 2019年第3期
- epilepsy healthcare utilization inpatient admissions institutionalized elderly population Medicare fee for service;
98.Pharmacy Integration

机译：药房整合
- 作者：David B. Nash;*
- 期刊名称：《American Health Drug Benefits》 | 2019年第2期
99.The Economic Value of Customized versus Off-the-Shelf Knee Implants in Medicare Fee-for-Service Beneficiaries

机译：定制和现成的膝关节植入物在Medicare服务付费受益人中的经济价值
- 作者：Mary I. OConnor;Brittany E. Blau
- 期刊名称：《American Health Drug Benefits》 | 2019年第2期
- customized knee implant Medicare fee-for-service off-the-shelf implants osteoarthritis per-member per-month spending total knee arthroplasty value;
100.The Challenge of Managing Atopic Dermatitis in the United States

机译：在美国管理特应性皮炎的挑战
- 作者：Steven R. Feldman;Linda S. Cox;Lindsay C. Strowd;Robert A. Gerber;Steven Faulkner;Debra Sierka;Timothy W. Smith;Joseph C. Cappelleri;Mark E. Levenberg;Gary M. Owens;*
- 期刊名称：《American Health Drug Benefits》 | 2019年第2期
- anti-inflammatory therapies atopic dermatitis dermatology economic impact financial burden medication adherence quality of life steroid phobia topical calcineurin inhibitors topical corticosteroids treatment guidelines;